Addition of Cilostazol to Conventional Dual Antiplatelet Therapy Reduces the Risk of Cardiac Events and Restenosis After Drug-Eluting Stent Implantation: A Meta-Analysis

Drug-Eluting Stents Versus Bare-Metal Stents in Saphenous Vein Graft Interventions

(2011) Matthew E. Wiisanen et al.   JACC-Cardiovascular Interventions

Inhibitory Effects of Cilostazol on Proliferation of Vascular Smooth Muscle Cells (VSMCs) Through Suppression of the ERK1/2 Pathway

(2011) A Rum Yoo et al.   Journal of Atherosclerosis and Thrombosis

Multicenter Randomized Trial Evaluating the Efficacy of Cilostazol on Ischemic Vascular Complications After Drug-Eluting Stent Implantation for Coronary Heart Disease

(2011) Jung-Won Suh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Randomized, Double-Blind, Multicenter Comparison Study of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy to Reduce Restenosis After Drug-Eluting Stent Implantation in Long Coronary Lesions

(2011) Seung-Whan Lee et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Addition of Cilostazol to Aspirin and a Thienopyridine for Prevention of Restenosis After Coronary Artery Stenting: A Meta-Analysis

(2010) Douglas L. Jennings et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: A randomized, controlled study

(2009) Yaling Han et al.   AMERICAN HEART JOURNAL

Long-term outcomes following coronary drug-eluting- and bare-metal-stent implantation

(2009) Johann Auer et al.   ATHEROSCLEROSIS

Triple antiplatelet therapyvs.dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: an evidence-based approach to answering a clinical query

(2009) Inderjeet Singh et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Cardiovascular Death and Nonfatal Myocardial Infarction in Acute Coronary Syndrome Patients Receiving Coronary Stenting Are Predicted by Residual Platelet Reactivity to ADP Detected by a Point-of-Care Assay

(2009) Rossella Marcucci et al.   CIRCULATION

Safety and Efficacy of Drug-Eluting and Bare Metal Stents

(2009) Ajay J. Kirtane et al.   CIRCULATION

Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention

(2008) Giuseppe G.L. Biondi-Zoccai et al.   AMERICAN HEART JOURNAL

Angiographic Patterns of Drug-Eluting Stent Restenosis and One-Year Outcomes After Treatment With Repeated Percutaneous Coronary Intervention

(2008) Emilia Solinas et al.   AMERICAN JOURNAL OF CARDIOLOGY

Point-of-Care Measurement of Clopidogrel Responsiveness Predicts Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention

(2008) Giuseppe Patti et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus

(2008) Seung-Whan Lee et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY